ArticleDementia & neuropsychologia2026
Teleneuropsychology in Latin America: Experiences and challenges during the COVID-19 pandemic.
Article in Dementia & neuropsychologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic accelerated the use of teleneuropsychology (TeleNP) to deliver remote neuropsychological services in settings with limited clinic access. Objective: To examine TeleNP practices in Latin America (LA), focusing on clinicians' perceptions of utility, validity, and barriers. Methods: A descriptive, exploratory cross-sectional survey was conducted between November 2020 and January 2021 among health professionals practicing neuropsychology in LA. The instrument, validated through a Delphi process, assessed professional background, TeleNP use, patient profiles, applied tests, and perceived advantages and challenges. Results: A total of 212 clinicians from 10 countries participated (mean age and clinical experience=42.7 years and 12.3 years, respectively). Participants were primarily psychologists (75.9%), but also neurologists, geriatricians, psychiatrists and speech-language pathologists. TeleNP adoption rose from 4.2% regular and 13.7% occasional pre-pandemic use to 58% at the time of the survey, with significant cross-country variation (χ Conclusion: TeleNP adoption in LA increased during the pandemic and is perceived as a valid, accessible modality to address geographic disparities in neuropsychological care. However, heterogeneous implementation, regulatory uncertainty, and technological limitations remain major challenges, underscoring the need for standardized guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.